Anorexiants is also termed appetite-suppressing drugs is a medication therapeutically developed to help in the management of obesity. This medication works by acting on the brain to suppress appetite and hence results in lower food consumption. Obesity is a chronic condition, in which excess body fat is accumulated to such an extent that it could have negative effects on the health of the individual. It occurs over time when people eat more calories than they utilize.
MARKET SCOPE
The "Global Anorexiants Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Anorexiants market with detailed market segmentation by drug class, route of administration, distribution channel and geography. The report provides key statistics on the market status of the leading Anorexiants market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on drug class, the global Anorexiants market is segmented into catecholamines anorexiants, serotonin anorexiants.
- Based on route of administration, the market is categorised into oral, subcutaneous.
- Based on distribution channel, the market is categorised into institutional sales, hospitals and clinics, retail sales, online pharmacies, mail order pharmacies.
MARKET DYNAMICS
Drivers:
- Increase in the burden of obesity-related disorders.
- Rise in availability of branded drugs
- Rise in the sedentary lifestyle, limited physical inactivity, and poor dietary habits resulted in weight gain
Restraints:
- Various side effects associated with anorexiants.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Anorexiants market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Anorexiants market in these regions.
IMPACT OF COVID-19 ON ANOREXIANTS MARKET
COVID-19 lockdown has resulted in challenges for people living with obesity. As during this period, the lifestyle was deeply modified: diet, activity, and sleep behaviors, home office, take care of child, social distancing. All of these modifications may have led to stress and anxiety. It has been previously demonstrated that high perceived stress levels are correlated with high preference for sweet and fat foods. In this situation, the incidences of binge eating disorder has also increased which is characterized by compulsive overeating or consuming abnormal amounts of food while feeling unable to stop and a loss of control. Thus, patients with binge eating disorders may have been more sensitive to the impact of lockdown and thus urgently would require appropriated care management.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Anorexiants market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Anorexiants market in these regions.
IMPACT OF COVID-19 ON ANOREXIANTS MARKET
COVID-19 lockdown has resulted in challenges for people living with obesity. As during this period, the lifestyle was deeply modified: diet, activity, and sleep behaviors, home office, take care of child, social distancing. All of these modifications may have led to stress and anxiety. It has been previously demonstrated that high perceived stress levels are correlated with high preference for sweet and fat foods. In this situation, the incidences of binge eating disorder has also increased which is characterized by compulsive overeating or consuming abnormal amounts of food while feeling unable to stop and a loss of control. Thus, patients with binge eating disorders may have been more sensitive to the impact of lockdown and thus urgently would require appropriated care management.
MARKET PLAYERS
The report covers key developments in the Anorexiants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Anorexiants market are anticipated to lucrative growth opportunities in the future with the rising demand for Anorexiants in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Anorexiants market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Akrimax Pharmaceuticals, LLC
- Teva Pharmaceuticals
- Janssen Ortho, LLC
- Roche Pharmaceuticals
- Arena Pharmaceuticals GmbH
- Novo Nordisk A/S
- Epic Pharma
- Patheon Pharmaceuticals Inc
- Catalent Pharma Solutions
- Recordati Rare Diseases Inc.
- MOVA Pharmaceuticals
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anorexiants Market - By Drug Classification
1.3.2 Anorexiants Market - By Route of Administration
1.3.3 Anorexiants Market - By Distribution Channel
1.3.4 Anorexiants Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANOREXIANTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANOREXIANTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANOREXIANTS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANOREXIANTS - GLOBAL MARKET OVERVIEW
6.2. ANOREXIANTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ANOREXIANTS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASSIFICATION
7.1. OVERVIEW
7.2. DRUG CLASSIFICATION MARKET FORECASTS AND ANALYSIS
7.3. CATECHOLAMINES ANOREXIANTS
7.3.1. Overview
7.3.2. Catecholamines Anorexiants Market Forecast and Analysis
7.4. SEROTONIN ANOREXIANTS
7.4.1. Overview
7.4.2. Serotonin Anorexiants Market Forecast and Analysis
8. ANOREXIANTS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. SUBCUTANEOUS
8.4.1. Overview
8.4.2. Subcutaneous Market Forecast and Analysis
9. ANOREXIANTS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. INSTITUTIONAL SALES
9.3.1. Overview
9.3.2. Institutional sales Market Forecast and Analysis
9.4. HOSPITALS AND CLINICS
9.4.1. Overview
9.4.2. Hospitals and Clinics Market Forecast and Analysis
9.5. RETAIL SALES
9.5.1. Overview
9.5.2. Retail sales Market Forecast and Analysis
9.6. ONLINE PHARMACIES
9.6.1. Overview
9.6.2. Online pharmacies Market Forecast and Analysis
9.7. MAIL ORDER PHARMACIES
9.7.1. Overview
9.7.2. Mail Order Pharmacies Market Forecast and Analysis
10. ANOREXIANTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anorexiants Market Overview
10.1.2 North America Anorexiants Market Forecasts and Analysis
10.1.3 North America Anorexiants Market Forecasts and Analysis - By Drug Classification
10.1.4 North America Anorexiants Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Anorexiants Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Anorexiants Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anorexiants Market
10.1.6.1.1 United States Anorexiants Market by Drug Classification
10.1.6.1.2 United States Anorexiants Market by Route of Administration
10.1.6.1.3 United States Anorexiants Market by Distribution Channel
10.1.6.2 Canada Anorexiants Market
10.1.6.2.1 Canada Anorexiants Market by Drug Classification
10.1.6.2.2 Canada Anorexiants Market by Route of Administration
10.1.6.2.3 Canada Anorexiants Market by Distribution Channel
10.1.6.3 Mexico Anorexiants Market
10.1.6.3.1 Mexico Anorexiants Market by Drug Classification
10.1.6.3.2 Mexico Anorexiants Market by Route of Administration
10.1.6.3.3 Mexico Anorexiants Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Anorexiants Market Overview
10.2.2 Europe Anorexiants Market Forecasts and Analysis
10.2.3 Europe Anorexiants Market Forecasts and Analysis - By Drug Classification
10.2.4 Europe Anorexiants Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Anorexiants Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Anorexiants Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anorexiants Market
10.2.6.1.1 Germany Anorexiants Market by Drug Classification
10.2.6.1.2 Germany Anorexiants Market by Route of Administration
10.2.6.1.3 Germany Anorexiants Market by Distribution Channel
10.2.6.2 France Anorexiants Market
10.2.6.2.1 France Anorexiants Market by Drug Classification
10.2.6.2.2 France Anorexiants Market by Route of Administration
10.2.6.2.3 France Anorexiants Market by Distribution Channel
10.2.6.3 Italy Anorexiants Market
10.2.6.3.1 Italy Anorexiants Market by Drug Classification
10.2.6.3.2 Italy Anorexiants Market by Route of Administration
10.2.6.3.3 Italy Anorexiants Market by Distribution Channel
10.2.6.4 Spain Anorexiants Market
10.2.6.4.1 Spain Anorexiants Market by Drug Classification
10.2.6.4.2 Spain Anorexiants Market by Route of Administration
10.2.6.4.3 Spain Anorexiants Market by Distribution Channel
10.2.6.5 United Kingdom Anorexiants Market
10.2.6.5.1 United Kingdom Anorexiants Market by Drug Classification
10.2.6.5.2 United Kingdom Anorexiants Market by Route of Administration
10.2.6.5.3 United Kingdom Anorexiants Market by Distribution Channel
10.2.6.6 Rest of Europe Anorexiants Market
10.2.6.6.1 Rest of Europe Anorexiants Market by Drug Classification
10.2.6.6.2 Rest of Europe Anorexiants Market by Route of Administration
10.2.6.6.3 Rest of Europe Anorexiants Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anorexiants Market Overview
10.3.2 Asia-Pacific Anorexiants Market Forecasts and Analysis
10.3.3 Asia-Pacific Anorexiants Market Forecasts and Analysis - By Drug Classification
10.3.4 Asia-Pacific Anorexiants Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Anorexiants Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Anorexiants Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anorexiants Market
10.3.6.1.1 Australia Anorexiants Market by Drug Classification
10.3.6.1.2 Australia Anorexiants Market by Route of Administration
10.3.6.1.3 Australia Anorexiants Market by Distribution Channel
10.3.6.2 China Anorexiants Market
10.3.6.2.1 China Anorexiants Market by Drug Classification
10.3.6.2.2 China Anorexiants Market by Route of Administration
10.3.6.2.3 China Anorexiants Market by Distribution Channel
10.3.6.3 India Anorexiants Market
10.3.6.3.1 India Anorexiants Market by Drug Classification
10.3.6.3.2 India Anorexiants Market by Route of Administration
10.3.6.3.3 India Anorexiants Market by Distribution Channel
10.3.6.4 Japan Anorexiants Market
10.3.6.4.1 Japan Anorexiants Market by Drug Classification
10.3.6.4.2 Japan Anorexiants Market by Route of Administration
10.3.6.4.3 Japan Anorexiants Market by Distribution Channel
10.3.6.5 South Korea Anorexiants Market
10.3.6.5.1 South Korea Anorexiants Market by Drug Classification
10.3.6.5.2 South Korea Anorexiants Market by Route of Administration
10.3.6.5.3 South Korea Anorexiants Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Anorexiants Market
10.3.6.6.1 Rest of Asia-Pacific Anorexiants Market by Drug Classification
10.3.6.6.2 Rest of Asia-Pacific Anorexiants Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Anorexiants Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anorexiants Market Overview
10.4.2 Middle East and Africa Anorexiants Market Forecasts and Analysis
10.4.3 Middle East and Africa Anorexiants Market Forecasts and Analysis - By Drug Classification
10.4.4 Middle East and Africa Anorexiants Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Anorexiants Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Anorexiants Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anorexiants Market
10.4.6.1.1 South Africa Anorexiants Market by Drug Classification
10.4.6.1.2 South Africa Anorexiants Market by Route of Administration
10.4.6.1.3 South Africa Anorexiants Market by Distribution Channel
10.4.6.2 Saudi Arabia Anorexiants Market
10.4.6.2.1 Saudi Arabia Anorexiants Market by Drug Classification
10.4.6.2.2 Saudi Arabia Anorexiants Market by Route of Administration
10.4.6.2.3 Saudi Arabia Anorexiants Market by Distribution Channel
10.4.6.3 U.A.E Anorexiants Market
10.4.6.3.1 U.A.E Anorexiants Market by Drug Classification
10.4.6.3.2 U.A.E Anorexiants Market by Route of Administration
10.4.6.3.3 U.A.E Anorexiants Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Anorexiants Market
10.4.6.4.1 Rest of Middle East and Africa Anorexiants Market by Drug Classification
10.4.6.4.2 Rest of Middle East and Africa Anorexiants Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Anorexiants Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anorexiants Market Overview
10.5.2 South and Central America Anorexiants Market Forecasts and Analysis
10.5.3 South and Central America Anorexiants Market Forecasts and Analysis - By Drug Classification
10.5.4 South and Central America Anorexiants Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Anorexiants Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Anorexiants Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anorexiants Market
10.5.6.1.1 Brazil Anorexiants Market by Drug Classification
10.5.6.1.2 Brazil Anorexiants Market by Route of Administration
10.5.6.1.3 Brazil Anorexiants Market by Distribution Channel
10.5.6.2 Argentina Anorexiants Market
10.5.6.2.1 Argentina Anorexiants Market by Drug Classification
10.5.6.2.2 Argentina Anorexiants Market by Route of Administration
10.5.6.2.3 Argentina Anorexiants Market by Distribution Channel
10.5.6.3 Rest of South and Central America Anorexiants Market
10.5.6.3.1 Rest of South and Central America Anorexiants Market by Drug Classification
10.5.6.3.2 Rest of South and Central America Anorexiants Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Anorexiants Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANOREXIANTS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANOREXIANTS MARKET, KEY COMPANY PROFILES
13.1. AKRIMAX PHARMACEUTICALS, LLC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. TEVA PHARMACEUTICALS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ROCHE PHARMACEUTICALS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ARENA PHARMACEUTICALS GMBH
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NOVO NORDISK A/S
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. JANSSEN ORTHO, LLC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. EPIC PHARMA, LLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PATHEON PHARMACEUTICALS INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. RECORDATI RARE DISEASES INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MOVA PHARMACEUTICALS.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Akrimax Pharmaceuticals, LLC
2. Teva Pharmaceuticals
3. Janssen Ortho, LLC
4. Roche Pharmaceuticals
5. Arena Pharmaceuticals GmbH
6. Novo Nordisk A/S
7. Epic Pharma
8. Patheon Pharmaceuticals Inc
9. Catalent Pharma Solutions
10. Recordati Rare Diseases Inc
11. MOVA Pharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For